ELP4 and cancer: While ELP4 and ELP5 mRNA expression are associated with olaparib sensitivity from univariate analysis of GDSC pan-cancer cell lines, ELP4 and ELP6 missense variants may contribute to sensitivity to olaparib in the HGSOC cell line TOV2978G.